Evaluating Patient Comfort and Environmental Conditions in the Carecube Negative Pressure Isolation Chamber.1

Sponsor
Carecubes, Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT05468723
Collaborator
University of Nebraska (Other)
11
1
25
13.4

Study Details

Study Description

Brief Summary

This is a human non-significant risk (NSR) clinical study designed to objectively and participatively verify that the Carecube Negative Pressure Isolation Chamber is a safe and non-hostile environment for the patients that will be contained within the chamber during normal operations.

Condition or Disease Intervention/Treatment Phase
  • Device: Carecube Negative Pressure Isolation Chamber

Detailed Description

Device Information:

The Carecube Negative Pressure Isolation Chamber is a patient isolation unit (PIU) designed for the temporary isolation of patients within a hospital to prevent particulate (biological) cross-contamination between user and patient, while enclosing the contaminated patient from the external environment.

Study Description:

Participants will be tasked to stay within the Carecube Negative Pressure Isolation Chamber for a minimum of three consecutive time points (1 hour apart) illustrating a plateau level for all parameters, up to a maximum of 7 hours (readings will be taken at baseline and hourly thereafter).

The Carecube Negative Pressure Isolation Chamber will be set up indoors, in an emergency department and hospital floor environment. We will collect data and demonstrate that the Carecube Isolation chamber is a safe and non-hostile environment for the patients that will be contained within, during normal operations.

Each participant will be asked to come to a test center facility to complete and sign the informed consent and receive instruction to interact with the simulation. Subjects will be tasked to stay within the Carecube Isolation Chamber for at least 4 hours and have 3 consecutive timepoints illustrating a plateau level for all participants parameters.

Environmental data will be collected by physicians and nurses. Additionally, atmospheric Oxygen, Carbon Dioxide, humidity, and room temperature will be monitored and recorded. External to the room humidity and temperatures will also be recorded. The participant will be exposed to room temperature (° Fahrenheit) and humidity (RH%), ranging from 65°- 90° Fahrenheit and 30%-60% RH. Participants will also be asked to record on a questionnaire, in order to demonstrate that the Carecube Negative Pressure Isolation chamber is a safe and non-hostile environment for the patients that will be contained during normal operations.

Study Design

Study Type:
Observational
Actual Enrollment :
11 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Evaluating Patient Comfort and Environmental Conditions in the Carecube Negative Pressure Isolation Chamber.1
Actual Study Start Date :
May 24, 2022
Actual Primary Completion Date :
Jun 18, 2022
Actual Study Completion Date :
Jun 18, 2022

Outcome Measures

Primary Outcome Measures

  1. Body Temperature [4 hours]

    Subject's body temperature maintains a normal healthy value based on their entry body temperature and outside the Carecube

  2. Blood Pressure [4 hours]

    Subject's blood pressure stays at a normal healthy level with respect to their initial baseline

  3. Pulse [4 hours]

    Subject's pulse stays within a normal healthy level based with respect to their initial baseline

  4. Oxygen levels [4 hours]

    Subject's Oxygen levels stays within a normal healthy level based with respect to their initial baseline

  5. Movement [4 hours]

    Subject is able to move within the Carecube, to include activities such as sitting up, laying down, rotating, foot flexion or other body positioning within the hospital bed located within the Carecube.

  6. Communication [4 hours]

    Subject and provider are able to clearly and effectively communicate while the Subject is positioned within the Carecube Negative Pressure Isolation Chamber.

  7. Environmental Condition [4 hours]

    Environment does not have an elevation of temperature, Carbon Dioxide and humidity outside a normal range as compared to the external environment of the chamber.

Secondary Outcome Measures

  1. Comfort [4 hours]

    Subject does not become uncomfortable or claustrophobic

  2. Anxiety [4 hours]

    Subject does not become anxious

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years to 64 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

Male, female, non-binary between the ages of 19-65 No existing medical condition that would impact the Subject from staying within the containment system for the specified time-period.

Patient is not pre-dispositioned for claustrophobia

Exclusion Criteria:

Subjects that have a pre-existing condition of claustrophobia Subjects that have a history of hypertension Subjects with a clinical diagnosis of generalized anxiety disorder (GAD) Subjects with a clinical diagnosis of major depressive disorder (MDD) Morbidly obese patients (BMI above 40) Subjects who are Women of Child Bearing Potential (WOCBP) who either are pregnant or suspect they are pregnant

Contacts and Locations

Locations

Site City State Country Postal Code
1 UNMC Omaha Nebraska United States 68198-8437

Sponsors and Collaborators

  • Carecubes, Inc.
  • University of Nebraska

Investigators

  • Principal Investigator: Andy Schnaubelt, UNMC

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Carecubes, Inc.
ClinicalTrials.gov Identifier:
NCT05468723
Other Study ID Numbers:
  • TP-00003 Revision: 05
First Posted:
Jul 21, 2022
Last Update Posted:
Jul 21, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 21, 2022